SunOpta director granted RSUs, converts to shares
SunOpta Inc. director David J. Lemmon reported equity compensation activity involving restricted stock units and common shares.
Rhea-AI Filing Summary
SunOpta Inc. director David J. Lemmon reported equity compensation activity involving restricted stock units and common shares. On May 29, 2025, he was granted 17,770 Restricted Stock Units, each representing a contingent right to receive one SunOpta common share and having no expiration date. On the same date, 14,023 Restricted Stock Units were exercised and converted into 14,023 common shares at a stated price of $0.00 per share, leaving 16,634 common shares held directly after the transactions. The filing is an amendment to add a transaction that was inadvertently omitted from the original Form 4, and it states that no additional transactions occurred after the original filing date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 17,770 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 14,023 | $0.00 | $0.00 |
| Exercise | Common Shares | 14,023 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
- F2. The Restricted Stock Units do not have an expiration date.
- F3. This Amendment to Form 4 is being filed to report a transaction that was inadvertently omitted from the original Form 4 filed on May 30, 2025. No additional transactions have occurred since the date of the original filing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SunOpta (STKL) director David J. Lemmon report?
How many Restricted Stock Units did the SunOpta (STKL) director receive?
Do the SunOpta (STKL) Restricted Stock Units reported have an expiration date?
Why was this SunOpta (STKL) Form 4/A filed as an amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.